HSP90AB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian Cancer
出版年份 2023 全文链接
标题
HSP90AB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian Cancer
作者
关键词
-
出版物
Oxidative Medicine and Cellular Longevity
Volume 2023, Issue -, Pages 1-24
出版商
Hindawi Limited
发表日期
2023-05-03
DOI
10.1155/2023/9335440
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
- (2022) Han Li et al. Journal for ImmunoTherapy of Cancer
- EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling
- (2021) Liqing Jia et al. BRITISH JOURNAL OF CANCER
- FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer
- (2021) Jing Zhao et al. BIOCHEMICAL PHARMACOLOGY
- An Escherichia coli Effector Protein EspF May Induce Host DNA Damage via Interaction With SMC1
- (2021) Muqing Fu et al. Frontiers in Microbiology
- Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis
- (2021) Rong Wang et al. Frontiers in Immunology
- Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance
- (2021) Kaoru Yamawaki et al. CANCER LETTERS
- MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
- (2021) Meysam Moghbeli Journal of Ovarian Research
- Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling
- (2021) Xun Sun et al. Theranostics
- Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells
- (2021) Ke-Xin Li et al. Cancers
- m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells
- (2020) Liang Hao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- Decreased Expression of Cystathionine β-Synthase Exacerbates Intestinal Barrier Injury in Ulcerative Colitis
- (2019) Shanwen Chen et al. Journal of Crohns & Colitis
- Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
- (2019) Yuening Xiang et al. Cancer Medicine
- Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor
- (2019) Guannan Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy
- (2019) Haim Werner et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Maggot Extracts Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis via the Activation of Nrf2
- (2019) Rong Wang et al. Oxidative Medicine and Cellular Longevity
- Antitumor effects of immunity-enhancing traditional Chinese medicine
- (2019) Yeshu Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
- (2019) Q. Sheng et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
- (2019) Robyn Laura Kosinsky et al. Cell Death & Disease
- Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
- (2018) Ting Li et al. Journal of Hematology & Oncology
- MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
- (2018) Yong Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hsp90ab1 stabilizes LRP5 to promote epithelial–mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression
- (2018) Huanan Wang et al. ONCOGENE
- Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein
- (2018) Brian Kawahara et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
- (2017) Jing Meng et al. Molecular Cancer
- Function of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy (Review)
- (2017) Jingsheng Yuan et al. Oncology Letters
- The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
- (2017) Rachel E. Lackie et al. Frontiers in Neuroscience
- IGF1R and c-met as therapeutic targets for colorectal cancer
- (2016) Hajar Shali et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- HSP90AB1: Helping the good and the bad
- (2016) Michael Haase et al. GENE
- Hsp90, the Concertmaster: Tuning Transcription
- (2015) Nidhi Khurana et al. Frontiers in Oncology
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
- (2013) Deborah K. Armstrong et al. GYNECOLOGIC ONCOLOGY
- Role of cMET in the Development and Progression of Colorectal Cancer
- (2013) Juan Pérez-Vargas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy
- (2013) C. Ferte et al. MOLECULAR CANCER THERAPEUTICS
- IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness
- (2012) Simona Pavan et al. EUROPEAN JOURNAL OF CANCER
- Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
- (2012) Rong Biaoxue et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
- (2011) Alessandro Inno et al. Clinical Colorectal Cancer
- Insect natural products and processes: New treatments for human disease
- (2011) Norman A. Ratcliffe et al. INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Housefly Maggots (Musca domestica) Protein-enriched Fraction/ extracts (PE) Inhibit Lipopolysaccharide-induced Atherosclerosis Pro-inflammatory Responses
- (2011) Fu-Jiang Chu et al. Journal of Atherosclerosis and Thrombosis
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Hsp90 is regulated by a switch point in the C-terminal domain
- (2009) Marco Retzlaff et al. EMBO REPORTS
- Impact of heat-shock protein 90 on cancer metastasis
- (2009) Shinji Tsutsumi et al. Future Oncology
- Expression of Hsp90 chaperome proteins in human tumor tissue
- (2009) Christina L. McDowell et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
- (2009) Rongshi Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic applications of the larvae for wound debridement
- (2009) Arif Turkmen et al. Journal of Plastic Reconstructive and Aesthetic Surgery
- Transforming Growth Factor (TGF )-Stimulated Secretion of HSP90 : Using the Receptor LRP-1/CD91 To Promote Human Skin Cell Migration against a TGF -Rich Environment during Wound Healing
- (2008) C.-F. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started